Abstract
Burkholderia cepacia complex (BCC) bacteria are a group of opportunistic pathogens that cause severe lung infections in cystic fibrosis (CF). Treatment of BCC infections is difficult, due to the inherent and acquired multidrug resistance of BCC. There is a pressing need to find new bacterial targets for antimicrobials. Here, we demonstrate that the novel compound Q22, which is related to the bacterial cytoskeleton destabilising compound A22, can reduce the growth rate and inhibit growth of BCC bacteria. We further analysed the phenotypic effects of Q22 treatment on BCC virulence traits, to assess its feasibility as an antimicrobial. BCC bacteria were grown in the presence of Q22 with a broad phenotypic analysis, including resistance to H₂O₂-induced oxidative stress, changes in the inflammatory potential of cell surface components, and in-vivo drug toxicity studies. The influence of the Q22 treatment on inflammatory potential was measured by monitoring the cytokine responses of BCC whole cell lysates, purified lipopolysaccharide, and purified peptidoglycan extracted from bacterial cultures grown in the presence or absence of Q22 in differentiated THP-1 cells. BCC bacteria grown in the presence of Q22 displayed varying levels of ...Continue Reading
References
Aug 1, 1975·Analytical Biochemistry·K Hayashi
Aug 1, 1980·International Journal of Cancer. Journal International Du Cancer·S TsuchiyaK Tada
Jul 3, 1993·Lancet·J R GovanA K Webb
Mar 6, 1999·Current Opinion in Microbiology·I Chopra
Feb 3, 2000·Journal of Clinical Microbiology·E MahenthiralingamP Vandamme
Feb 13, 2001·Microbiology·M Lefebre, M Valvano
Feb 25, 2003·Bioscience, Biotechnology, and Biochemistry·Noritaka IwaiMasaaki Wachi
Mar 27, 2004·American Journal of Respiratory and Critical Care Medicine·Anthony De SoyzaRaquel Demarco de Hormaeche
Jun 10, 2005·Rapid Communications in Mass Spectrometry : RCM·Luisa SturialeAntonio Molinaro
Dec 1, 2005·The Journal of Biological Chemistry·Johan BylundDavid P Speert
Oct 7, 2006·Applied Microbiology and Biotechnology·Waldemar Vollmer
Jan 11, 2007·Bioscience, Biotechnology, and Biochemistry·Noritaka IwaiTomoya Kitazume
Jan 16, 2007·Chemistry : a European Journal·Alba SilipoMichelangelo Parrilli
Jul 24, 2007·Journal of Bacteriology·Gregory T RobertsonA Simon Lynch
Aug 21, 2007·Journal of Bacteriology·Preeti SrivastavaDhruba K Chattoraj
Jul 2, 2008·Biological & Pharmaceutical Bulletin·Norihisa NoguchiMasanori Sasatsu
Jul 23, 2008·Environmental Microbiology·Luisa PironeFiorentina Ascenzioni
Dec 22, 2009·Journal of Bacteriology·Constantin N TakacsChristine Jacobs-Wagner
Jan 21, 2010·Infection and Immunity·Annette C VergunstDavid O'Callaghan
Mar 9, 2010·Experimental Lung Research·Malcolm BrodlieChristopher Ward
Apr 20, 2010·Molecular Microbiology·Kimberly N Cowles, Zemer Gitai
Sep 18, 2010·The European Respiratory Journal·L A BorthwickA J Fisher
Oct 14, 2011·International Journal of Antimicrobial Agents·Audrey NicholsonF Kate Gould
Dec 24, 2011·Analytical Biochemistry·Nhat Khai BuiWaldemar Vollmer
Feb 1, 2012·PLoS Pathogens·David M BulmerC M Anjam Khan
Mar 12, 2013·Bioorganic & Medicinal Chemistry Letters·Courtney A BarkerEric D Brown
Mar 22, 2013·PloS One·Heleen Van AckerTom Coenye
Citations
Oct 12, 2018·International Journal of Molecular Sciences·Francesco Blasi
Sep 19, 2019·Scientific Reports·Betty L SlingerHelen E Blackwell
Oct 3, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Linda VáradiPaul W Groundwater
Jan 31, 2020·Frontiers in Chemistry·Elvis Awuni